FDA Product Quality Reviews Could Become Team Effort To Improve Consistency
This article was originally published in The Pink Sheet Daily
Executive Summary
CDER Director Janet Woodcock says when an NDA nears patent expiry and generics are preparing for market entry, reviewers would hand it off to a life-cycle team that would also handle associated ANDAs.